Co-Authors
This is a "connection" page, showing publications co-authored by Christopher Goetz and Paul Carvey.
Connection Strength
0.910
-
Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations. Neurology. 1998 Feb; 50(2):515-7.
Score: 0.156
-
Animal models of tardive dyskinesia: their use in the search for new treatment methods. Mod Probl Pharmacopsychiatry. 1983; 21:5-20.
Score: 0.055
-
Gender and pramipexole effects on levodopa pharmacokinetics and pharmacodynamics. Neurology. 2002 May 14; 58(9):1418-22.
Score: 0.053
-
The role of the serotonin system in animal models of myoclonus. Adv Neurol. 2002; 89:244-8.
Score: 0.051
-
Posthypoxic myoclonus in the rat: natural history, stability, and serotonergic influences. Mov Disord. 2000; 15 Suppl 1:39-46.
Score: 0.045
-
Animal model of posthypoxic myoclonus: effects of serotonergic antagonists. Neurology. 1999 Jan 01; 52(1):16-21.
Score: 0.042
-
5-Hydroxytryptophan-induced myoclonus in guinea pigs: mediation through 5-HT1/2 receptor subtypes. Eur J Pharmacol. 1998 Apr 17; 347(1):51-6.
Score: 0.040
-
The stability of carbidopa in solution. Mov Disord. 1997 Jul; 12(4):608-10.
Score: 0.038
-
Liquid levodopa/carbidopa produces significant improvement in motor function without dyskinesia exacerbation. Neurology. 1996 Dec; 47(6):1493-5.
Score: 0.036
-
Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels. Neurology. 1996 Oct; 47(4):1037-42.
Score: 0.036
-
Levodopa stability in solution: time course, environmental effects, and practical recommendations for clinical use. Mov Disord. 1996 Jan; 11(1):24-6.
Score: 0.034
-
Blood levodopa levels and unified Parkinson's disease rating scale function: with and without exercise. Neurology. 1993 May; 43(5):1040-2.
Score: 0.028
-
Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures. Exp Neurol. 1993 Mar; 120(1):149-52.
Score: 0.028
-
Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures. Exp Neurol. 1991 Oct; 114(1):28-34.
Score: 0.025
-
The potential use of a dopamine neuron antibody and a striatal-derived neurotrophic factor as diagnostic markers in Parkinson's disease. Neurology. 1991 May; 41(5 Suppl 2):53-8; discussion 59-60.
Score: 0.024
-
Disappearance of a putative DA-neuron antibody following adrenal medulla transplantation: relationship to a striatal-derived DA neuron trophic factor. Prog Brain Res. 1990; 82:693-7.
Score: 0.022
-
An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation. Neurosci Lett. 1988 Nov 22; 94(1-2):192-7.
Score: 0.021
-
Controlled-release carbidopa/levodopa (CR4-Sinemet) in Parkinson's disease patients with and without motor fluctuations. Neurology. 1988 Jul; 38(7):1143-6.
Score: 0.020
-
Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation. Life Sci. 1988; 42(22):2207-15.
Score: 0.019
-
The effect of thioridazine on haloperidol induced behavioral hypersensitivity. Life Sci. 1986 May 12; 38(19):1707-14.
Score: 0.017
-
The effect of antimuscarinic agents on haloperidol induced behavioral hypersensitivity. Eur J Pharmacol. 1986 Jan 21; 120(2):193-9.
Score: 0.017
-
Drug-induced myoclonus. Adv Neurol. 1986; 43:251-64.
Score: 0.017
-
L-5-HTP-induced myoclonic jumping behavior in guinea pigs: an update. Adv Neurol. 1986; 43:509-17.
Score: 0.017
-
The pathophysiology of tardive dyskinesia. J Clin Psychiatry. 1985 Apr; 46(4 Pt 2):38-41.
Score: 0.016
-
Neuroleptic-induced dopamine hyposensitivity. Life Sci. 1984 Apr 09; 34(15):1475-9.
Score: 0.015
-
Animal models of tardive dyskinesias. Clin Neuropharmacol. 1983 Jun; 6(2):129-35.
Score: 0.014
-
Estrogen supplementation in the posthypoxic myoclonus rat model. Clin Neuropharmacol. 2001 Jan-Feb; 24(1):58-61.
Score: 0.012
-
Clinical improvement in parkinsonian patients undergoing adrenal to caudate transplantation is not reflected by chromogranin A or basic fibroblast growth factor in ventricular fluid. Exp Neurol. 1991 Mar; 111(3):276-81.
Score: 0.006
-
Effect of chronic levodopa on haloperidol-induced behavioral supersensitivity in the guinea pig. Adv Neurol. 1982; 35:213-9.
Score: 0.003
-
The effect of chronic levodopa on haloperidol induced behavioral supersensitivity in the guinea pig. Life Sci. 1981 May 11; 28(19):2173-8.
Score: 0.003